Current trader consensus assigning an 88.5% probability to no new COVID variant of concern before 2027 reflects sustained low risk from circulating SARS-CoV-2 strains. No variants currently meet WHO or ECDC criteria for VOC designation, with all active lineages descending from Omicron and showing no evidence of substantially increased severity, immune escape, or transmissibility that would trigger reclassification. BA.3.2, first detected in late 2024 and rising in some regions through early 2026, remains a variant under monitoring with low public health impact assessments. Ongoing genomic surveillance and population-level immunity from prior infections and vaccines continue to limit disruptive shifts, while reduced case volumes and sequencing have slowed emergence signals. A new VOC would require unexpected mutations producing clear clinical or epidemiological changes not observed in recent sublineages such as XFG or NB.1.8.1.